Neurodegeneration: Microglia: Nf-Kappab Signaling Pathways

Abstract

Microglia is cells of mesodermal/mesenchymal origin that migrate into the central nervous system (CNS) to form resident macrophages inside the special brain microenvironment. Intact with both neuronal and non-neuronal cells, microglia is highly active cells. Continuous process extension and retraction allows microglia to scan the brain parenchyma for threats. They are also able to change their morphology from ramified to amoeboid, which is a sign of cell activity. In response to pleiotropic stimuli such as neurotransmitters, cytokines, and plasma proteins, microglia express a diverse range of receptors. As controllers of synaptic activities and phagocytosis of developing neurons, they serve a critical role in the healthy brain and have significant effects on synaptic plasticity and adult neurogenesis. A frequent cause of hypoparathyroidism is a mutation in the gene glial cells missing-2 (GCM2). Neonatal hypoparathyroidism has an amorphic recessive GCM2 mutation, while autosomal dominant hypoparathyroidism has a dominant-negative GCM2 mutation. Curiously, familial isolated hyperparathyroidism has been associated with activating GCM2 mutation. In addition to seizures, neurocognitive impairment, carpopedal spasm, tingling and numbness are common clinical manifestations of hypoparathyroidism. Biogenic amines are a group of four neurotransmitters that belong to that category and these include serotonin, dopamine, norepinephrine, and epinephrine. Numerous antidepressants prevent the reuptake from occurring the brain-gut axis is hardwired through the CNS, enteric nervous system (ENS), neuroendocrine linkages and highly innervated nerve plexuses.

Key words

Microglia - Central Nervous System - Enteric Nervous System - Neurocognitive impairment - Receptor - Dopamine.

Publication History

Received: 11 July 2022

Accepted: 01 August 2022

Article published online:
02 September 2022

• References

• 1 Farfara D, Lifshitz V, Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer’s disease. Journal of cellular and molecular medicine 2008; 12: 762-780 c(Dutta et al., 2008; Cunningham, 2013)
• 2 Cao Z, Qin T, Liu TY. et al. June). Learning to rank: from pairwise approach to listwise approach. In Proceedings of the 24th international conference on Machine learning 2007; pp. 129-136
• 3 Wang Y, Schmeichel AM, Iida H. et al. Enhanced inflammatory response via activation of NF-κB in acute experimental diabetic neuropathy subjected to ischemia – reperfusion injury. Journal of the neurological sciences 2006; 247: 47-52
• 4 Li P, Bukhari SNA, Khan T. et al. Apigenin-loaded solid lipid nanoparticle attenuates diabetic nephropathy induced by streptozotocin nicotinamide through Nrf2/HO-1/NF-kB signalling pathway. International journal of nanomedicine 2020; 15: 9115
• 5 Adki KM, Kulkarni YA. Biomarkers in diabetic neuropathy. Archives of Physiology and Biochemistry 2020; 1-16
• 6 Law A, Gauthier S, Quirion R. Say NO to Alzheimer’s disease: the putative links between nitric oxide and dementia of the Alzheimer’s type. Brain research reviews 2001; 35: 73-96
• 7 Heneka MT, Carson MJ, El Khoury J. et al. Neuroinflammation in Alzheimer’s disease. The Lancet Neurology 2015; 14: 388-405
• 8 Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochemical pharmacology 2014; 88: 594-604
• 9 Tansey MG, Frank-Cannon TC, McCoy MK. et al. Neuroinflammation in Parkinson’s disease: is there sufficient evidence for mechanism-based interventional therapy?. Frontiers in Bioscience-Landmark 2008; 13: 709-717
• 10 Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 2004; 44: 181-193
• 11 Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Disease-a-month: DM 2010; 56: 484
• 12 Liu PP, Xie Y, Meng XY. et al. History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal transduction and targeted therapy 2019; 4: 1-22
• 13 Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease – a brief review of the basic science and clinical literature. Cold Spring Harbor perspectives in medicine 2012; 2: a006346
• 14 Mosher KI, Wyss-Coray T. Microglial dysfunction in brain aging and Alzheimer’s disease. Biochemical pharmacology 2014; 88: 594-604
• 15 Czirr E, Wyss-Coray T. The immunology of neurodegeneration. The Journal of clinical investigation 2012; 122: 1156-1163
• 16 Zhang R, Miller RG, Madison C. et al. “Systemic immune system alterations in early stages of Alzheimer’s disease.”. Journal of neuroimmunology 2013; 256 no. 1-2 (2013) 38-42
• 17 Oeckinghaus A, Ghosh S. The NF-κB family of transcription factors and its regulation. Cold Spring Harbor perspectives in biology 2009; 1: a000034
• 18 Bonizzi G, Karin M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends in immunology 2004; 25: 280-288
• 19 Chen FE, Huang DB, Chen YQ. et al. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA. Nature 1998; 391: 410-413
• 20 Bachiller S, Jiménez-Ferrer I, Paulus A. et al. Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Frontiers in cellular neuroscience 2018; 12: 488
• 21 Shih RH, Wang CY, Yang CM. NF-kappaB signaling pathways in neurological inflammation: a mini review. Frontiers in molecular neuroscience 2015; 8: 77
• 22 Das A, Kim SH, Arifuzzaman S. et al. Transcriptome sequencing reveals that LPS-triggered transcriptional responses in established microglia BV2 cell lines are poorly representative of primary microglia. Journal of neuroinflammation 2016; 13: 1-18
• 23 Abere B, Wikan N, Ubol S. et al. Proteomic analysis of chikungunya virus infected microgial cells. PloS one 2012; 7: e34800
• 24 Prechel MM, Ding C, Washington RL. et al. In vivo indomethacin treatment causes microgial activation in adult mice. Neurochemical research 2000; 25: 357-362
• 25 Buffalino R. Sex Differences in Microgial Activation and Neuroinflammation On a High Fat Diet in Mice. 2019
• 26 Rayan NA. A Study On Anti-Inflannatory And Neuroprotective Effects Os Costunolide On Lipopolysaccharide Activated Murine Brain Microgial. 2013
• 27 Le YY, Cui YH, Gong WH. et al. TNF alpha up-regulates the expression and function of amyloid beta receptor in murine microgial cells. FASEB Journal 2002; 16: A1085-A1085
• 28 Wierzba-Bobrowicz T, Lewandowska E, Kosno-Kruszewska E. et al. Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics. Folia Neuropathologica 2004; 42: 157-165
• 29 Nobuta H. STAT3-mediated Reactive Astrocytes Control Microgial TGF [beta]-1 Expression and Protect Myelin Development After Neonatal Inflammatory Insult (Doctoral dissertation, University of California, Los Angeles). 2011
• 30 Ulrich J, Ipsen S, Probst A. et al. Alzheimer’s disease: Epitopes characteristics of paired helical filaments demonstrated in microgial cells and macrophages of the meninges.: A possibility for the laboratory diagnosis of Alzheimer’s disease from cerebrospinal fluid?. In Biological markers of Alzheimer’s disease. 1989. pp. 66-72 Springer Verlag;
• 31 Das BK, Mukherjee SC. A histopathological study of carp (Labeo rohita) exposed to hexachlorocyclohexane. Veterinarski arhiv 2000; 70: 169-180
• 32 Santiago AR, Bernardino L, Agudo-Barriuso M. et al. Microglia in health and disease: a double-edged sword. Mediators of Inflammation 2017; 2017: 7034143 DOI: 10.1155/2017/7034143.
• 33 Ahn SM, Byun K, Cho K. et al. Human microglial cells synthesize albumin in brain. PloS one 2008; 3: e2829
• 34 Sanderson D, Pitt J. August). An affective anticipatory agent architecture. In 2011 IEEE/WIC/ACM International Conferences on Web Intelligence and Intelligent Agent Technology.2011: Vol. 2: pp. 93–96. IEEE